3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
The healthcare industry evolves rapidly. Those companies that stay relevant often do so by breaking new ground. So it's a good idea for investors looking for exciting healthcare stocks to look at companies that have demonstrated innovative capabilities. Of course, that alone isn't enough to make them attractive picks, but it's a great start.
With that in mind, let's look at three revolutionary stocks investors can buy right now: Abbott Laboratories (NYSE: ABT), CRISPR Therapeutics (NASDAQ: CRSP), and Moderna (NASDAQ: MRNA).
As a leading medical device company, Abbott Laboratories has stood the test of time. The healthcare giant's recipe for success includes its ability to develop innovative devices that improve patients' lives. Abbott's portfolio now features dozens of products. Last year, the company won innovation awards for four of its products, including its continuous glucose monitoring (CGM) system, the FreeStyle Libre.
Source Fool.com
Abbott Laboratories Aktie
Mit 20 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung steht die Community der Abbott Laboratories Aktie positiv gegenüber.
Das Kursziel von 115 € für Abbott Laboratories impliziert eine leichte Steigerung gegenüber dem aktuellen Kurs von 100.16 €.
